DETERMINANTS OF OPTIC AXON OUTGROWTH
视轴突生长的决定因素
基本信息
- 批准号:3260322
- 负责人:
- 金额:$ 11.98万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:1984
- 资助国家:美国
- 起止时间:1984-03-01 至 1991-02-28
- 项目状态:已结题
- 来源:
- 关键词:antibody axon cell cell interaction cell migration electron microscopy embryo /fetus eye transplantation gene expression growth inhibitors histochemistry /cytochemistry histology immunochemistry microscopy nervous system regeneration neural plasticity neuronal transport tissue /cell culture visual cortex
项目摘要
An antibody has been identified to a cell surface protein, designated M6,
which blocks neurite outgrowth in vitro. Studies on the developing optic
nerve in vivo indicate that M6 is expressed only up to a certain critical
period of development. The biological function in vitro and the pattern of
expression in vivo suggested that by knowing more about the behavior of the
antigen and its antibody, we would gain further insight into why optic
axons stop growing during development and why they generally fail to
regenerate after injury. Additional results collected over the past year
confirm this expectation and indicate that a substantial investigation of
the antigen and its antibody centered on the primary optic pathway is
justified.
This proposal focuses on three areas: (1) We wish to examine the
hypothesis that the antigen is involved in vivo with the processes of
axonal growth and cell migration. (2) We wish to use the antibody to
arrest irreversibly both cell migration and axonal outgrowth as a tool for
studying various interdependencies occurring during development and after
injury. (3) We wish to examine how the context in which a neuron develops
may regulate the expression of the M6 antigen and as a result modify
neurite outgrowth and cell migration patterns.
Nine individual experiments are proposed, each of which addresses one or
more of the three areas raised. Collectively, they should provide insight
into the behavior in vivo of an antigen which appears to regulate neurite
extension by a molecular mechanism which is under investigation in parallel
studies. They will also exploit the use of the antibody both as a probe
and a label for investigating plasticity and regeneration of the visual
system.
已经鉴定了一种针对细胞表面蛋白质的抗体,命名为M6,
在体外阻断神经突生长。 显影光学的研究
神经在体内表明,M6的表达只有达到一定的临界值,
发展时期。 体外生物学功能和细胞形态
体内表达表明,通过了解更多关于
抗原及其抗体,我们将进一步了解为什么光学
轴突在发育过程中停止生长,以及为什么它们通常不能
损伤后再生。 过去一年收集的其他结果
确认这一预期,并指出,一个实质性的调查,
以初级视路为中心的抗原及其抗体,
正当的
这项建议集中在三个方面:(一)我们希望研究
假设抗原在体内参与以下过程:
轴突生长和细胞迁移。 (2)我们希望用抗体
不可逆地阻止细胞迁移和轴突生长,
研究在发育过程中和发育后发生的各种相互依赖关系
损伤 (3)我们希望研究神经元发育的环境
可以调节M6抗原的表达,并因此修饰
神经突生长和细胞迁移模式。
提出了九个单独的实验,每个实验都涉及一个或多个问题。
这三个领域中的更多。 总的来说,他们应该提供洞察力
一种似乎调节神经突的抗原在体内的行为
通过分子机制进行延伸,
问题研究 他们还将利用抗体作为探针,
以及一个研究视觉的可塑性和再生的标签
系统
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
RAYMOND D LUND其他文献
RAYMOND D LUND的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('RAYMOND D LUND', 18)}}的其他基金
相似海外基金
An atypical microtubule generation mechanism for neurons drives dendrite and axon development and regeneration
神经元的非典型微管生成机制驱动树突和轴突的发育和再生
- 批准号:
23K21316 - 财政年份:2024
- 资助金额:
$ 11.98万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Characterizing Wnt Signaling Pathways in Axon Guidance
轴突引导中 Wnt 信号通路的特征
- 批准号:
10815443 - 财政年份:2023
- 资助金额:
$ 11.98万 - 项目类别:
2023 NINDS Landis Mentorship Award - Administrative Supplement to NS121106 Control of Axon Initial Segment in Epilepsy
2023 年 NINDS 兰迪斯指导奖 - NS121106 癫痫轴突初始段控制的行政补充
- 批准号:
10896844 - 财政年份:2023
- 资助金额:
$ 11.98万 - 项目类别:
Does phosphorylation regulation of the axon initial segment cytoskeleton improve behavioral abnormalities in ADHD-like animal models?
轴突起始段细胞骨架的磷酸化调节是否可以改善 ADHD 样动物模型的行为异常?
- 批准号:
23KJ1485 - 财政年份:2023
- 资助金额:
$ 11.98万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Loss-of-function variants of the axon death protein SARM1 and protection from human neurodegenerative disease
轴突死亡蛋白 SARM1 的功能丧失变体和对人类神经退行性疾病的保护
- 批准号:
2891744 - 财政年份:2023
- 资助金额:
$ 11.98万 - 项目类别:
Studentship
Collaborative Research: Evolution of ligand-dependent Robo receptor activation mechanisms for axon guidance
合作研究:用于轴突引导的配体依赖性 Robo 受体激活机制的进化
- 批准号:
2247939 - 财政年份:2023
- 资助金额:
$ 11.98万 - 项目类别:
Standard Grant
Understanding the degeneration of axon and nerve terminals in Alzheimer's disease and related dementia brain
了解阿尔茨海默病和相关痴呆大脑中轴突和神经末梢的变性
- 批准号:
10661457 - 财政年份:2023
- 资助金额:
$ 11.98万 - 项目类别:
Unlocking BIN1 function in oligodendrocytes and support of axon integrity
解锁少突胶质细胞中的 BIN1 功能并支持轴突完整性
- 批准号:
10901005 - 财政年份:2023
- 资助金额:
$ 11.98万 - 项目类别:
Regulating axon guidance through local translation at adhesions
通过粘连处的局部翻译调节轴突引导
- 批准号:
10587090 - 财政年份:2023
- 资助金额:
$ 11.98万 - 项目类别:
The role of RNA methylation in cytoskeleton regulation during axon development
RNA甲基化在轴突发育过程中细胞骨架调节中的作用
- 批准号:
22KF0399 - 财政年份:2023
- 资助金额:
$ 11.98万 - 项目类别:
Grant-in-Aid for JSPS Fellows